These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 34649008)

  • 1. Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis.
    Haukoos JS; White DAE; Rowan SE; Lyle C; Gravitz S; Basham K; Godoy A; Kamis K; Hopkins E; Anderson E;
    Am J Emerg Med; 2022 Jan; 51():6-12. PubMed ID: 34649008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients.
    Haukoos JS; White DAE; Rowan SE; Lyle C; Gravitz S; Basham K; Godoy A; Kamis K; Hopkins E; Anderson E
    AIDS Patient Care STDS; 2021 Jun; 35(6):211-219. PubMed ID: 34097464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Screening for HIV Pre-Exposure Prophylaxis Eligibility in Two Emergency Departments in Washington, DC.
    Kulie P; Castel AD; Zheng Z; Powell NN; Srivastava A; Chandar S; McCarthy ML
    AIDS Patient Care STDS; 2020 Dec; 34(12):516-522. PubMed ID: 33296271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated proportion of an urban academic emergency department patient population eligible for HIV preexposure prophylaxis.
    Faryar KA; Ancona RM; Braun RS; Brown JL; Sickles RK; Lyons MS
    Am J Emerg Med; 2021 Oct; 48():198-202. PubMed ID: 33975131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an Electronic Algorithm for Identifying Cisgender Female Pre-Exposure Prophylaxis Candidates.
    Ridgway JP; Friedman EE; Bender A; Schmitt J; Cronin M; Brown RN; Johnson AK; Hirschhorn LR
    AIDS Patient Care STDS; 2021 Jan; 35(1):5-8. PubMed ID: 33400588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptance of HIV pre-exposure prophylaxis (PrEP) referral among a sample of PrEP-eligible emergency department patients.
    Faryar KA; Braun R; Ancona RM; Freiermuth C; Lyons MS
    Am J Emerg Med; 2022 Oct; 60():152-155. PubMed ID: 35973343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
    BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK.
    O'Halloran C; Croxford S; Mohammed H; Gill ON; Hughes G; Fifer H; Allen H; Owen G; Nutland W; Delpech V; Saunders JM
    Sex Transm Infect; 2021 Sep; 97(6):429-433. PubMed ID: 33082235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Patients in the Emergency Department Should Receive Preexposure Prophylaxis? Implementation of a Predictive Analytics Approach.
    Ridgway JP; Almirol EA; Bender A; Richardson A; Schmitt J; Friedman E; Lancki N; Leroux I; Pieroni N; Dehlin J; Schneider JA
    AIDS Patient Care STDS; 2018 May; 32(5):202-207. PubMed ID: 29672136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of HIV Pre-exposure Prophylaxis (PrEP) Implementation in U.S. Emergency Departments: Patient Screening, Prescribing, and Linkage to Care.
    Jackson KJ; Chitle P; McCoy SI; White DAE
    J Community Health; 2024 Jun; 49(3):499-513. PubMed ID: 38127296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Rates of Pre-exposure Prophylaxis Eligibility and Associated HIV Incidence in a Population With a Generalized HIV Epidemic in Rakai, Uganda.
    Ssempijja V; Nakigozi G; Ssekubugu R; Kagaayi J; Kigozi G; Nalugoda F; Nantume B; Batte J; Kigozi G; Yeh PT; Nakawooya H; Serwadda D; Quinn TC; Gray RH; Wawer MJ; Grabowski KM; Chang LW; Van't Hoog A; Cobelens F; Reynolds SJ
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):291-299. PubMed ID: 35259129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
    Calabrese SK; Willie TC; Galvao RW; Tekeste M; Dovidio JF; Safon CB; Blackstock O; Taggart T; Kaplan C; Caldwell A; Kershaw TS
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):395-405. PubMed ID: 30973543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study.
    Krakower DS; Gruber S; Hsu K; Menchaca JT; Maro JC; Kruskal BA; Wilson IB; Mayer KH; Klompas M
    Lancet HIV; 2019 Oct; 6(10):e696-e704. PubMed ID: 31285182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England.
    Mitchell HD; Desai S; Mohammed H; Ong KJ; Furegato M; Hall V; Desai M; Saunders JM; Hughes G; Field N; Gill ON
    Sex Transm Infect; 2019 Nov; 95(7):484-487. PubMed ID: 31010953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Club drug users had higher odds of reporting a bacterial STI compared with non-club drug users: results from a cross-sectional analysis of gay and bisexual men on HIV pre-exposure prophylaxis.
    John SA; Parsons JT; Rendina HJ; Grov C
    Sex Transm Infect; 2019 Dec; 95(8):626-628. PubMed ID: 30126949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing Laboratory Results to Identify Emergency Department Patients with Indications for HIV Pre-Exposure Prophylaxis.
    Carlisle NA; Booth JS; Rodgers JB; Heath SL; Walter LA
    AIDS Patient Care STDS; 2022 Aug; 36(8):285-290. PubMed ID: 35951447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
    Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC;
    Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Preexposure (PrEP) Eligibility Criteria, Using Sexually Transmissible Infections as Markers of Human Immunodeficiency Virus (HIV) Risk at Enrollment in PrEPX, a Large Australian HIV PrEP Trial.
    Cornelisse VJ; Fairley CK; Stoove M; Asselin J; Chow EPF; Price B; Roth NJ; Willcox J; Tee BK; Penn M; Chang CC; Armishaw J; Forgan-Smith G; Wright EJ;
    Clin Infect Dis; 2018 Nov; 67(12):1847-1852. PubMed ID: 29741665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.